Investeringspodcasten
Afsnit 259: Novo Nordisk, DeepSeek vs Nvidia, Genmab og kommende regnskaber
29 Jan 2025
Novo Nordisk leverede gode data på Amycretin. DeepSeek sendte Nvidia ned – hvad skal der ske nu? Hør også om skuffede Genmab-investorer, de kommende regnskaber og meget mere i afsnit 259 af Investeringspodcasten.00:00 Intro00:48 DeepSeek vs Nvidia 09:23 Novo Nordisk19:57 Genmab27:15 Amerikansk rentemødeBesøg Pers Univers herFølg Per Hansen på XFølg Per Hansen på LinkedIn
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast